|Mr. Steven A. Sherman||Exec. Chairman||100k||N/A||1946|
|Mr. Jack Peurach||Pres, CEO & Director||275k||N/A||1966|
|Mr. John F. Glenn||CFO & Sec.||281.02k||N/A||1962|
|Mr. William R. Shaw||Chief Commercial Officer||N/A||N/A||1974|
|Ms. Foon Lim Chwee||Pres of APAC||N/A||N/A||N/A|
|Mr. Matthias Stief||Managing Director of Ekso Bionics Europe GmbH||N/A||N/A||N/A|
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. It primarily offers EksoNR, a bionic suit that provides the ability to stand and walk over ground with a full weight-bearing, reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke; and EksoUE, a wearable assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms, as well as reduce fatigue while rehabilitation sessions to achieve a larger active range of motion. The company's Ekso devices are primarily used in a hospital and rehabilitation setting. It has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.
Ekso Bionics Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.